GHK-Cu

At a glance

Overview

GHK is a three-amino-acid sequence that can bind copper; GHK-Cu is the resulting complex. Cosmetic ingredient lists commonly use copper tripeptide-1. These two names refer to the same copper-peptide complex, although skincare products and experimental preparations can have substantially different formulations. The copper complex is also distinct from unbound GHK, palmitoyl tripeptide-1, and AHK-Cu. Such differences matter when evaluating a paper or product. Many appealing claims concern cell cultures, animal wounds, or related molecules. Those findings can motivate research, but cannot establish that a particular serum regrows hair or that an injected product repairs multiple human organs.

Supporting sources [1] [2] [3] [4] [5]

How it works

Experiments have examined collagen synthesis, extracellular-matrix remodeling, and responses of repair-associated cells. Copper binding changes the chemical context of GHK and may influence biological activity. The relevant mechanism is not a single universally validated regenerative pathway. Tissue, formulation, exposure, and the exact peptide complex all matter; a collagen signal in fibroblasts cannot alone predict a visible or clinically useful effect in intact human skin.

Supporting sources [1] [2] [3] [4] [5]

The human study is more restrained than the marketing

A small randomized post-laser study had thirteen completers. GHK-Cu products did not significantly improve objective redness resolution, wrinkles, or overall skin quality compared with control care, although patient satisfaction favored the GHK-Cu regimen. This is useful direct human evidence, but it is not broad confirmation of anti-aging or wound-healing efficacy.

Supporting sources [1]

What the experimental work contributes

Fibroblast research found increased collagen synthesis, and rat wound studies examined connective-tissue accumulation. These experiments address biological plausibility. They do not establish the same outcome in an intact human face or after systemic injection. Some hair literature often associated with GHK-Cu actually studies AHK-Cu, a different tripeptide.

Supporting sources [2] [3] [4]

Topical cosmetics and injections are separate questions

FDA notes limited human safety data and potential immunogenicity concerns for compounded injectable GHK-Cu. Cosmetic availability does not authorize that route. A topical product’s tolerability depends on its complete formulation, while systemic benefit and long-term injectable safety remain unestablished.

Supporting sources [5]

Frequently asked questions

Are copper tripeptide-1 and GHK-Cu different actives?
They name the same copper complex. Unbound GHK, palmitoyl tripeptide-1, and AHK-Cu are different chemical forms or sequences.

Does the human hair-follicle paper establish GHK-Cu hair growth?
The cited 2007 experiment studied AHK-Cu, not GHK-Cu, and used follicles and cells outside a clinical treatment trial. It cannot establish GHK-Cu hair regrowth in people.

Supporting sources [2] [4]